Current and historical daily PE Ratio for Voyager Therapeutics Inc (
) from 2015 to Apr 18 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Voyager Therapeutics stock (VYGR) PE ratio as of Apr 18 2024 is 2.49.
More Details
Voyager Therapeutics Inc (VYGR) PE Ratio (TTM) Chart
Voyager Therapeutics Inc (VYGR) PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Total 1211
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Voyager Therapeutics PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-19 | 2.5 | 2024-02-14 | 2.4 |
| 2024-04-18 | 2.5 | 2024-02-13 | 2.4 |
| 2024-04-17 | 2.5 | 2024-02-12 | 2.5 |
| 2024-04-16 | 2.6 | 2024-02-09 | 2.5 |
| 2024-04-15 | 2.7 | 2024-02-08 | 2.5 |
| 2024-04-12 | 2.8 | 2024-02-07 | 2.5 |
| 2024-04-11 | 2.9 | 2024-02-06 | 2.4 |
| 2024-04-10 | 2.9 | 2024-02-05 | 2.4 |
| 2024-04-09 | 3.0 | 2024-02-02 | 2.5 |
| 2024-04-08 | 3.0 | 2024-02-01 | 2.5 |
| 2024-04-05 | 3.1 | 2024-01-31 | 2.4 |
| 2024-04-04 | 3.0 | 2024-01-30 | 2.5 |
| 2024-04-03 | 3.1 | 2024-01-29 | 2.5 |
| 2024-04-02 | 3.3 | 2024-01-26 | 2.5 |
| 2024-04-01 | 3.5 | 2024-01-25 | 2.5 |
| 2024-03-28 | 3.1 | 2024-01-24 | 2.5 |
| 2024-03-27 | 3.2 | 2024-01-23 | 2.5 |
| 2024-03-26 | 3.3 | 2024-01-22 | 2.5 |
| 2024-03-25 | 3.1 | 2024-01-19 | 2.5 |
| 2024-03-22 | 3.0 | 2024-01-18 | 2.4 |
| 2024-03-21 | 3.1 | 2024-01-17 | 2.4 |
| 2024-03-20 | 3.4 | 2024-01-16 | 2.5 |
| 2024-03-19 | 3.3 | 2024-01-12 | 2.6 |
| 2024-03-18 | 3.0 | 2024-01-11 | 2.6 |
| 2024-03-15 | 3.1 | 2024-01-10 | 2.8 |
| 2024-03-14 | 3.0 | 2024-01-09 | 2.9 |
| 2024-03-13 | 3.0 | 2024-01-08 | 3.0 |
| 2024-03-12 | 3.0 | 2024-01-05 | 2.9 |
| 2024-03-11 | 3.0 | 2024-01-04 | 3.6 |
| 2024-03-08 | 3.1 | 2024-01-03 | 3.5 |
| 2024-03-07 | 3.1 | 2024-01-02 | 3.0 |
| 2024-03-06 | 3.0 | 2023-12-29 | 2.8 |
| 2024-03-05 | 3.0 | 2023-12-28 | 2.9 |
| 2024-03-04 | 3.2 | 2023-12-27 | 7.1 |
| 2024-03-01 | 3.1 | 2023-12-26 | 7.1 |
| 2024-02-29 | 2.8 | 2023-12-22 | 6.9 |
| 2024-02-28 | 3.0 | 2023-12-21 | 6.6 |
| 2024-02-27 | 2.9 | 2023-12-20 | 6.5 |
| 2024-02-26 | 2.9 | 2023-12-19 | 6.7 |
| 2024-02-23 | 2.7 | 2023-12-18 | 6.5 |
| 2024-02-22 | 2.5 | 2023-12-15 | 6.5 |
| 2024-02-21 | 2.5 | 2023-12-14 | 6.3 |
| 2024-02-20 | 2.5 | 2023-12-13 | 6.3 |
| 2024-02-16 | 2.5 | 2023-12-12 | 6.0 |
| 2024-02-15 | 2.5 | 2023-12-11 | 6.2 |
Voyager Therapeutics Inc (VYGR) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Voyager Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US92915B1061
Compare
Compare
Traded in other countries / regions
VYGR.USAVYGR.MexicoVT6.Germany IPO Date
2015-11-11Description
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers